Ohcanbohtosat - Mingyan E

  • Čájehuvvo 1 - 4 / 4
Aiddostahte ozu
  1. 1
    Bearbmagovva

    Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours Dahkki Guohui Liu, Chunbo Wang, Yunlong He, Mingyan E

    Almmustuhtton 2019
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bearbmagovva

    Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma Dahkki Yamin Jie, Jianing Wu, Dongxue An, Man Li, Hongjiang He, Duo Wang, Anxin Gu, Mingyan E

    Almmustuhtton 2023
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Bearbmagovva

    Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells' resistance to anti-tumour drugs Dahkki Meng Chi, Yamin Jie, Ying Li, Ying Li, Duo Wang, Man Li, Dan Li, Mingyan E, Yongwu Li, Na Liu, Anxin Gu, Guanghua Rong

    Almmustuhtton 2023
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Bearbmagovva

    The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses Dahkki Yungchang Chen, Hao Sun, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Mingyan E, Hongqiang Guo, Mengmeng Wu, Chunman Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Huawei Weng, Xue Wu, Yang Shao, Anxin Gu, Tongyu Lin

    Almmustuhtton 2023
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: